2025 ASPNR-ASNR Research Grant

PURPOSE:

To fund neuroradiology research that advances the understanding, diagnosis, and/or treatment of central nervous system pathologies in children.  

APPLICABILITY:

  • This grant provides up to $20,000 for a 1-year project to support the pilot phase of a scientific project.
  • The grant period runs from February 1, 2025, to January 31, 2026.
  • The application consists of a two-step process: submission of a Letter of Intent followed by an invitation to submit a research grant application to those who have submitted the most promising projects.

ELIGIBILITY:

  • The grant is open to applicants from low-GDP countries (MD or equivalent in radiology).
  • Radiologists with research proposal in pediatric neuroradiology
  • An applicant must be an ASPNR and ASNR member in good standing and remain so throughout the duration of the award. Not an ASPNR member? Join here.
  • Applicant(s) must not be agents of any for-profit or commercial company in the medical sciences.
  • The grant cannot be supplemental to external or internal funding from a single grant, combined grants, or contracts from any source greater than $25,000 secured within the past three years for the same or for a substantially similar project.
  • External or internal supplemental grant support <$20,000 must be detailed within the budget. Supplemental funding from other grant sources may be approved if the investigator submits a satisfactory plan to address any budgetary overlap.
  • Only one submission per applicant is permitted.

EXCLUSIONS:

  • Applicants from sanctioned countries will be excluded
  • Former ASPNR research grant award recipients.
  • Members of the ASPNR Board of Directors and members of the ASPNR Research Grant Committee.

TIMELINES:

  • Deadline for Letters of Intent is June 30, 2024, 11:59 pm EST. Click hereto submit your LOI
  • Complete grant applications (upon invitation) must be submitted by September 1, 2024, 11:59 pm EST. 
  • The recipient of the 2025 ASPNR-ASNR Research Grant will be announced at the 7th Annual ASPNR Meeting in January 2025 in Austin, TX.